Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People

Background: Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hy...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical medicine Vol. 9; no. 6; p. 1920
Main Authors Kushkevych, Ivan, Castro Sangrador, Jorge, Dordević, Dani, Rozehnalová, Monika, Černý, Martin, Fafula, Roman, Vítězová, Monika, Rittmann, Simon K.-M. R.
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 19.06.2020
MDPI
Subjects
Online AccessGet full text
ISSN2077-0383
2077-0383
DOI10.3390/jcm9061920

Cover

Abstract Background: Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hydrogen sulfide (H2S) by dissimilatory sulfate reduction. The aims of our research were to physiologically examine SRB in fecal samples of patients with IBD and a control group, their identification, the study of the process of dissimilatory sulfate reduction (sulfate consumption and H2S production) and biomass accumulation. Determination of biogenic elements of the SRB and evaluation of obtained parameters by using statistical methods were also included in the research. The material for the research consisted of 14 fecal samples, which was obtained from patients and control subjects. Methods: Microscopic techniques, microbiological, biochemical, biophysical methods and statistical analysis were included. Results: Colonies of SRB were isolated from all the fecal samples, and subsequently, 35 strains were obtained. Vibrio-shaped cells stained Gram-negative were dominant in all purified studied strains. All strains had a high percentage of similarity by the 16S rRNA gene with deposited sequences in GenBank of Desulfovibrio vulgaris. Cluster analysis of sulfate reduction parameters allowed the grouping of SRB strains. Significant (p < 0.05) differences were not observed between healthy individuals and patients with IBD with regard to sulfate reduction parameters (sulfate consumption, H2S and biomass accumulation). Moreover, we found that manganese and iron contents in the cell extracts are higher among healthy individuals in comparison to unhealthy individuals that have an intestinal bowel disease, especially ulcerative colitis. Conclusions: The observations obtained from studying SRB emphasize differences in the intestinal microbial processes of healthy and unhealthy people.
AbstractList Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hydrogen sulfide (H2S) by dissimilatory sulfate reduction. The aims of our research were to physiologically examine SRB in fecal samples of patients with IBD and a control group, their identification, the study of the process of dissimilatory sulfate reduction (sulfate consumption and H2S production) and biomass accumulation. Determination of biogenic elements of the SRB and evaluation of obtained parameters by using statistical methods were also included in the research. The material for the research consisted of 14 fecal samples, which was obtained from patients and control subjects.BACKGROUNDInflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hydrogen sulfide (H2S) by dissimilatory sulfate reduction. The aims of our research were to physiologically examine SRB in fecal samples of patients with IBD and a control group, their identification, the study of the process of dissimilatory sulfate reduction (sulfate consumption and H2S production) and biomass accumulation. Determination of biogenic elements of the SRB and evaluation of obtained parameters by using statistical methods were also included in the research. The material for the research consisted of 14 fecal samples, which was obtained from patients and control subjects.Microscopic techniques, microbiological, biochemical, biophysical methods and statistical analysis were included.METHODSMicroscopic techniques, microbiological, biochemical, biophysical methods and statistical analysis were included.Colonies of SRB were isolated from all the fecal samples, and subsequently, 35 strains were obtained. Vibrio-shaped cells stained Gram-negative were dominant in all purified studied strains. All strains had a high percentage of similarity by the 16S rRNA gene with deposited sequences in GenBank of Desulfovibrio vulgaris. Cluster analysis of sulfate reduction parameters allowed the grouping of SRB strains. Significant (p < 0.05) differences were not observed between healthy individuals and patients with IBD with regard to sulfate reduction parameters (sulfate consumption, H2S and biomass accumulation). Moreover, we found that manganese and iron contents in the cell extracts are higher among healthy individuals in comparison to unhealthy individuals that have an intestinal bowel disease, especially ulcerative colitis.RESULTSColonies of SRB were isolated from all the fecal samples, and subsequently, 35 strains were obtained. Vibrio-shaped cells stained Gram-negative were dominant in all purified studied strains. All strains had a high percentage of similarity by the 16S rRNA gene with deposited sequences in GenBank of Desulfovibrio vulgaris. Cluster analysis of sulfate reduction parameters allowed the grouping of SRB strains. Significant (p < 0.05) differences were not observed between healthy individuals and patients with IBD with regard to sulfate reduction parameters (sulfate consumption, H2S and biomass accumulation). Moreover, we found that manganese and iron contents in the cell extracts are higher among healthy individuals in comparison to unhealthy individuals that have an intestinal bowel disease, especially ulcerative colitis.The observations obtained from studying SRB emphasize differences in the intestinal microbial processes of healthy and unhealthy people.CONCLUSIONSThe observations obtained from studying SRB emphasize differences in the intestinal microbial processes of healthy and unhealthy people.
Background: Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hydrogen sulfide (H2S) by dissimilatory sulfate reduction. The aims of our research were to physiologically examine SRB in fecal samples of patients with IBD and a control group, their identification, the study of the process of dissimilatory sulfate reduction (sulfate consumption and H2S production) and biomass accumulation. Determination of biogenic elements of the SRB and evaluation of obtained parameters by using statistical methods were also included in the research. The material for the research consisted of 14 fecal samples, which was obtained from patients and control subjects. Methods: Microscopic techniques, microbiological, biochemical, biophysical methods and statistical analysis were included. Results: Colonies of SRB were isolated from all the fecal samples, and subsequently, 35 strains were obtained. Vibrio-shaped cells stained Gram-negative were dominant in all purified studied strains. All strains had a high percentage of similarity by the 16S rRNA gene with deposited sequences in GenBank of Desulfovibrio vulgaris. Cluster analysis of sulfate reduction parameters allowed the grouping of SRB strains. Significant (p < 0.05) differences were not observed between healthy individuals and patients with IBD with regard to sulfate reduction parameters (sulfate consumption, H2S and biomass accumulation). Moreover, we found that manganese and iron contents in the cell extracts are higher among healthy individuals in comparison to unhealthy individuals that have an intestinal bowel disease, especially ulcerative colitis. Conclusions: The observations obtained from studying SRB emphasize differences in the intestinal microbial processes of healthy and unhealthy people.
Background: Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hydrogen sulfide (H 2 S) by dissimilatory sulfate reduction. The aims of our research were to physiologically examine SRB in fecal samples of patients with IBD and a control group, their identification, the study of the process of dissimilatory sulfate reduction (sulfate consumption and H 2 S production) and biomass accumulation. Determination of biogenic elements of the SRB and evaluation of obtained parameters by using statistical methods were also included in the research. The material for the research consisted of 14 fecal samples, which was obtained from patients and control subjects. Methods: Microscopic techniques, microbiological, biochemical, biophysical methods and statistical analysis were included. Results: Colonies of SRB were isolated from all the fecal samples, and subsequently, 35 strains were obtained. Vibrio-shaped cells stained Gram-negative were dominant in all purified studied strains. All strains had a high percentage of similarity by the 16S rRNA gene with deposited sequences in GenBank of Desulfovibrio vulgaris . Cluster analysis of sulfate reduction parameters allowed the grouping of SRB strains. Significant ( p < 0.05) differences were not observed between healthy individuals and patients with IBD with regard to sulfate reduction parameters (sulfate consumption, H 2 S and biomass accumulation). Moreover, we found that manganese and iron contents in the cell extracts are higher among healthy individuals in comparison to unhealthy individuals that have an intestinal bowel disease, especially ulcerative colitis. Conclusions: The observations obtained from studying SRB emphasize differences in the intestinal microbial processes of healthy and unhealthy people.
Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing microorganisms, sulfate-reducing bacteria (SRB) are suggested to be involved in the process of bowel inflammation due to the production of hydrogen sulfide (H S) by dissimilatory sulfate reduction. The aims of our research were to physiologically examine SRB in fecal samples of patients with IBD and a control group, their identification, the study of the process of dissimilatory sulfate reduction (sulfate consumption and H S production) and biomass accumulation. Determination of biogenic elements of the SRB and evaluation of obtained parameters by using statistical methods were also included in the research. The material for the research consisted of 14 fecal samples, which was obtained from patients and control subjects. Microscopic techniques, microbiological, biochemical, biophysical methods and statistical analysis were included. Colonies of SRB were isolated from all the fecal samples, and subsequently, 35 strains were obtained. Vibrio-shaped cells stained Gram-negative were dominant in all purified studied strains. All strains had a high percentage of similarity by the 16S rRNA gene with deposited sequences in GenBank of . Cluster analysis of sulfate reduction parameters allowed the grouping of SRB strains. Significant ( < 0.05) differences were not observed between healthy individuals and patients with IBD with regard to sulfate reduction parameters (sulfate consumption, H S and biomass accumulation). Moreover, we found that manganese and iron contents in the cell extracts are higher among healthy individuals in comparison to unhealthy individuals that have an intestinal bowel disease, especially ulcerative colitis. The observations obtained from studying SRB emphasize differences in the intestinal microbial processes of healthy and unhealthy people.
Author Castro Sangrador, Jorge
Dordević, Dani
Černý, Martin
Fafula, Roman
Kushkevych, Ivan
Rozehnalová, Monika
Vítězová, Monika
Rittmann, Simon K.-M. R.
AuthorAffiliation 4 Centre of Region Hana for Biotechnological an Agricultural Research, Central Laboratories and Research Support, Faculty of Science, Palacky University Olomouc, 77900 Olomouc, Czech Republic; Jarosova.Monika@email.cz
3 Department of Plant Origin Foodstuffs Hygiene and Technology, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences, 61242 Brno, Czech Republic; dani_dordevic@yahoo.com
2 Faculty of Biology, University of Salamanca, Campus Miguel de Unamuno C/Donantes de sangre, s/n 37007 Salamanca, Spain
5 Department of Medical Biophysics, Danylo Halytsky Lviv National Medical University, 69 Pekarska St., 79010 Lviv, Ukraine; roman_fafula@ukr.net
1 Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic; jorgecas@usal.es (J.C.S.); cernyarchaea@mail.muni.cz (M.C.); vitezova@sci.muni.cz (M.V.)
6 Archaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Un
AuthorAffiliation_xml – name: 6 Archaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Universität Wien, Althanstraße 14, 1090 Vienna, Austria
– name: 2 Faculty of Biology, University of Salamanca, Campus Miguel de Unamuno C/Donantes de sangre, s/n 37007 Salamanca, Spain
– name: 1 Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic; jorgecas@usal.es (J.C.S.); cernyarchaea@mail.muni.cz (M.C.); vitezova@sci.muni.cz (M.V.)
– name: 4 Centre of Region Hana for Biotechnological an Agricultural Research, Central Laboratories and Research Support, Faculty of Science, Palacky University Olomouc, 77900 Olomouc, Czech Republic; Jarosova.Monika@email.cz
– name: 3 Department of Plant Origin Foodstuffs Hygiene and Technology, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences, 61242 Brno, Czech Republic; dani_dordevic@yahoo.com
– name: 5 Department of Medical Biophysics, Danylo Halytsky Lviv National Medical University, 69 Pekarska St., 79010 Lviv, Ukraine; roman_fafula@ukr.net
Author_xml – sequence: 1
  givenname: Ivan
  orcidid: 0000-0002-8450-7137
  surname: Kushkevych
  fullname: Kushkevych, Ivan
– sequence: 2
  givenname: Jorge
  surname: Castro Sangrador
  fullname: Castro Sangrador, Jorge
– sequence: 3
  givenname: Dani
  orcidid: 0000-0002-2435-9726
  surname: Dordević
  fullname: Dordević, Dani
– sequence: 4
  givenname: Monika
  surname: Rozehnalová
  fullname: Rozehnalová, Monika
– sequence: 5
  givenname: Martin
  orcidid: 0000-0002-8231-9634
  surname: Černý
  fullname: Černý, Martin
– sequence: 6
  givenname: Roman
  surname: Fafula
  fullname: Fafula, Roman
– sequence: 7
  givenname: Monika
  surname: Vítězová
  fullname: Vítězová, Monika
– sequence: 8
  givenname: Simon K.-M. R.
  orcidid: 0000-0002-9746-3284
  surname: Rittmann
  fullname: Rittmann, Simon K.-M. R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32575467$$D View this record in MEDLINE/PubMed
BookMark eNptkttq3DAQhkVJaY43fYBi6E0JuJUs27JuCk2aNguBLEl7bWbl0a4WWdpIcmCfoS9d5dA0DdWNxPzf_IxmZp_sOO-QkLeMfuRc0k9rNUraMlnRV2SvokKUlHd859l7lxzFuKb5dF1dMfGG7PKqEU3dij3y6-wW7ATJeFd4XcxX22i89UujwBZzCDBiwhDvtJlLGJNxWbierIaE5RUOkzJuWZyAypiBYha9zcpQ6ODHbJAMuhRzgtZZz-R9fHbytQA3FOcINq22xRz9xuIhea3BRjx6vA_Iz29nP07Py4vL77PTLxelqmmbSiHrhjesWbCq5ZqjZqJGNUixqIZGIwVRc-iU5LyiQwtAWxgGxVDDotMAmh-Qzw--m2kx4qByhQFsvwlmhLDtPZj-X8WZVb_0t73gjaBVkw0-PBoEfzPlpvSjiQqtBYd-in1Vs1byrpM0o-9foGs_hdzDTLU1oy1nUmbq3fOKnkr5M6cMHD8AKvgYA-onhNH-bg_6v3uQYfoCVibdjzj_xtj_pfwGOle30g
CitedBy_id crossref_primary_10_1016_j_heliyon_2023_e15452
crossref_primary_10_3390_ijms22084007
crossref_primary_10_3390_pr9101843
crossref_primary_10_1186_s12866_021_02112_6
crossref_primary_10_3390_app11020735
crossref_primary_10_3390_jcm9082347
crossref_primary_10_3390_jcm10030462
crossref_primary_10_1016_j_biopha_2022_113079
crossref_primary_10_3390_diagnostics10100798
crossref_primary_10_1038_s41598_023_41185_3
crossref_primary_10_1016_j_csbj_2025_02_026
crossref_primary_10_1016_j_biopha_2021_112452
crossref_primary_10_2166_wh_2024_005
crossref_primary_10_3920_BM2022_0022
crossref_primary_10_3390_nu16183138
crossref_primary_10_1007_s12664_024_01541_1
crossref_primary_10_3390_app11031152
crossref_primary_10_3390_pathogens12020262
crossref_primary_10_1007_s11356_023_27460_w
crossref_primary_10_1186_s40168_023_01722_8
crossref_primary_10_3390_diagnostics13142387
Cites_doi 10.2754/avb201585010003
10.1128/9781555816834
10.1016/S0167-7012(00)00154-8
10.1017/CBO9781139170840
10.1128/jb.173.2.697-703.1991
10.3390/en11123270
10.1007/0-387-29298-5
10.1016/j.micpath.2017.09.054
10.3390/cells9030698
10.1007/s00203-018-1510-6
10.3390/jcm8101656
10.1016/S0016-5085(98)70381-6
10.1007/s00726-009-0445-2
10.33263/BRIAC94.066069
10.1097/00001574-199907000-00003
10.1098/rstb.1982.0091
10.1111/j.1751-2980.2007.00310.x
10.1515/med-2019-0010
10.33073/pjm-2015-016
10.2478/s11756-018-0118-2
10.1016/j.jab.2016.01.005
10.3748/wjg.v12.i30.4807
10.1007/s00203-019-01625-z
10.1016/j.jab.2018.01.004
10.3109/10408448409029321
10.1515/biol-2017-0009
10.3390/jcm8071054
10.1111/j.1572-0241.2004.04129.x
10.2754/avb201786040405
10.1136/gut.39.1.1
10.1007/s00044-017-2067-7
10.1111/j.1574-6968.1991.tb04799.x
10.1111/j.1574-6941.2002.tb00942.x
10.1099/00207713-26-2-238
10.3390/biom9120752
10.1002/bjs.6454
10.1515/biol-2018-0057
10.1515/med-2018-0052
10.1158/1541-7786.MCR-05-0126
10.3390/molecules21111558
10.1111/j.1365-2672.1988.tb01498.x
10.1515/biol-2018-0017
10.1006/jfca.1993.1016
ContentType Journal Article
Copyright 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 by the authors. 2020
Copyright_xml – notice: 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 by the authors. 2020
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3390/jcm9061920
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database

PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-0383
ExternalDocumentID PMC7357025
32575467
10_3390_jcm9061920
Genre Journal Article
GeographicLocations Czech Republic
GeographicLocations_xml – name: Czech Republic
GrantInformation_xml – fundername: Grant Agency of the Masaryk University
  grantid: MUNI/A/0947/2019
GroupedDBID 53G
5VS
7X7
8FI
8FJ
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
FYUFA
HMCUK
HYE
IAO
IHR
ITC
KQ8
M48
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c406t-79453515b1263f3ef174ecd97b2d5fe0a743a8c93320d6aa06addc1efab8faaf3
IEDL.DBID 7X7
ISSN 2077-0383
IngestDate Thu Aug 21 14:10:40 EDT 2025
Thu Sep 04 15:28:06 EDT 2025
Mon Jun 30 13:40:05 EDT 2025
Mon Jul 21 06:02:20 EDT 2025
Tue Jul 01 04:34:08 EDT 2025
Thu Apr 24 23:09:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords toxicity
bowel disease
intestinal microbiota
ulcerative colitis
hydrogen sulfide
sulfate reduction
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c406t-79453515b1263f3ef174ecd97b2d5fe0a743a8c93320d6aa06addc1efab8faaf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2435-9726
0000-0002-8450-7137
0000-0002-8231-9634
0000-0002-9746-3284
OpenAccessLink https://www.proquest.com/docview/2641063199?pq-origsite=%requestingapplication%
PMID 32575467
PQID 2641063199
PQPubID 5046890
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7357025
proquest_miscellaneous_2416938890
proquest_journals_2641063199
pubmed_primary_32575467
crossref_primary_10_3390_jcm9061920
crossref_citationtrail_10_3390_jcm9061920
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200619
PublicationDateYYYYMMDD 2020-06-19
PublicationDate_xml – month: 6
  year: 2020
  text: 20200619
  day: 19
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Journal of clinical medicine
PublicationTitleAlternate J Clin Med
PublicationYear 2020
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Rowan (ref_7) 2009; 96
ref_10
Kushkevych (ref_27) 2017; 86
Scaldaferri (ref_4) 2007; 8
Kushkevych (ref_22) 2015; 62
ref_51
Kushkevych (ref_50) 2018; 200
Kushkevych (ref_21) 2015; 84
ref_17
Kushkevych (ref_8) 2019; 201
Loubinoux (ref_6) 2002; 40
Kushkevych (ref_37) 2016; 14
Gibson (ref_12) 1991; 86
ref_25
ref_20
Kushkevych (ref_18) 2019; 9
ref_29
Kushkevych (ref_39) 2020; 25
Danese (ref_2) 2004; 99
Pitcher (ref_19) 1996; 39
Abdulina (ref_36) 2020; 10
Beauchamp (ref_52) 1984; 13
Kushkevych (ref_38) 2018; 27
Kushkevych (ref_26) 2018; 13
Kolmert (ref_46) 2000; 41
Wagner (ref_54) 2006; 4
Blachier (ref_53) 2010; 39
ref_35
Weisburg (ref_44) 1991; 173
Kushkevych (ref_16) 2015; 64
Kushkevych (ref_30) 2017; 12
Florin (ref_49) 1993; 6
Kushkevych (ref_33) 2018; 13
Kushkevych (ref_14) 2018; 16
Loubinoux (ref_34) 2002; 52
Kushkevych (ref_23) 2018; 73
Peck (ref_32) 1982; 298
Kushkevych (ref_40) 2020; 25
Kushkevych (ref_15) 2015; 36
ref_47
Fiocchi (ref_5) 1998; 115
ref_45
ref_43
ref_42
Gibson (ref_28) 1988; 65
Kushkevych (ref_31) 2018; 13
Cummings (ref_11) 2003; 4
Coutinho (ref_13) 2017; 112
ref_48
ref_9
Katz (ref_1) 1999; 15
Danese (ref_3) 2006; 12
Moore (ref_41) 1976; 26
Kushkevych (ref_24) 2019; 14
References_xml – volume: 84
  start-page: 3
  year: 2015
  ident: ref_21
  article-title: Activity of Na+/K+-activated Mg2+-dependent ATP hydrolase in the cell-free extracts of the sulfate-reducing bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9
  publication-title: Acta Vet. Brno
  doi: 10.2754/avb201585010003
– ident: ref_45
  doi: 10.1128/9781555816834
– volume: 41
  start-page: 179
  year: 2000
  ident: ref_46
  article-title: A fast and simple turbidimetric method for the determination of sulfate in sulfate-reducing bacterial cultures
  publication-title: J. Microbiol. Methods
  doi: 10.1016/S0167-7012(00)00154-8
– ident: ref_48
  doi: 10.1017/CBO9781139170840
– volume: 173
  start-page: 697
  year: 1991
  ident: ref_44
  article-title: 16S ribosomal DNA amplification for phylogenetic study
  publication-title: J. Bacteriol.
  doi: 10.1128/jb.173.2.697-703.1991
– volume: 52
  start-page: 1305
  year: 2002
  ident: ref_34
  article-title: Reclassification of the only species of the genus Desulfomonas, Desulfomonas pigra, as Desulfovibrio piger comb. nov
  publication-title: Int. J. Syst. Evol. Microbiol.
– ident: ref_29
  doi: 10.3390/en11123270
– ident: ref_42
  doi: 10.1007/0-387-29298-5
– volume: 112
  start-page: 126
  year: 2017
  ident: ref_13
  article-title: Sulphate-reducing bacteria from ulcerative colitis patients induce apoptosis of gastrointestinal epithelial cells
  publication-title: Microb. Pathog.
  doi: 10.1016/j.micpath.2017.09.054
– ident: ref_51
  doi: 10.3390/cells9030698
– ident: ref_35
– volume: 200
  start-page: 945
  year: 2018
  ident: ref_50
  article-title: The diversity of sulfate-reducing bacteria in the seven bioreactors
  publication-title: Arch. Microbiol.
  doi: 10.1007/s00203-018-1510-6
– ident: ref_20
  doi: 10.3390/jcm8101656
– volume: 10
  start-page: 55
  year: 2020
  ident: ref_36
  article-title: ATP sulfurylase activity of sulfate-reducing bacteria from various ecotopes
  publication-title: 3Biotech
– volume: 115
  start-page: 182
  year: 1998
  ident: ref_5
  article-title: Inflammatory bowel disease: Etiology and pathogenesis
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(98)70381-6
– volume: 39
  start-page: 335
  year: 2010
  ident: ref_53
  article-title: Luminal sulfide and large intestine mucosa: Friend or foe?
  publication-title: Amino Acids
  doi: 10.1007/s00726-009-0445-2
– volume: 25
  start-page: 1
  year: 2020
  ident: ref_40
  article-title: Possible synergy effect of hydrogen sulfide and acetate produced by sulfate-reducing bacteria on inflammatory bowel disease development
  publication-title: J. Adv. Res.
– volume: 9
  start-page: 4066
  year: 2019
  ident: ref_18
  article-title: Possible methods for evaluation of hydrogen sulfide toxicity against lactic acid bacteria
  publication-title: Biointerface Res. Appl. Chem.
  doi: 10.33263/BRIAC94.066069
– volume: 15
  start-page: 291
  year: 1999
  ident: ref_1
  article-title: Pathogenesis of inflammatory bowel disease
  publication-title: Curr. Opin. Gastroenterol.
  doi: 10.1097/00001574-199907000-00003
– ident: ref_17
– volume: 298
  start-page: 443
  year: 1982
  ident: ref_32
  article-title: Biochemistry of dissimilatory sulfate reduction
  publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci.
  doi: 10.1098/rstb.1982.0091
– volume: 8
  start-page: 171
  year: 2007
  ident: ref_4
  article-title: Inflammatory bowel disease: Progress and current concepts of etiopathogenesis
  publication-title: J. Dig. Dis.
  doi: 10.1111/j.1751-2980.2007.00310.x
– volume: 14
  start-page: 66
  year: 2019
  ident: ref_24
  article-title: Analysis of pH dose-dependent growth of sulfate-reducing bacteria
  publication-title: Open Med.
  doi: 10.1515/med-2019-0010
– volume: 64
  start-page: 107
  year: 2015
  ident: ref_16
  article-title: Kinetic properties of pyruvate ferredoxin oxidoreductase of intestinal sulfate-reducing bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9
  publication-title: Pol. J. Microbiol.
  doi: 10.33073/pjm-2015-016
– volume: 73
  start-page: 1137
  year: 2018
  ident: ref_23
  article-title: Cross-correlation analysis of the Desulfovibrio growth parameters of intestinal species isolated from people with colitis
  publication-title: Biologia
  doi: 10.2478/s11756-018-0118-2
– ident: ref_47
– volume: 14
  start-page: 125
  year: 2016
  ident: ref_37
  article-title: Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria
  publication-title: J. Appl. Biomed.
  doi: 10.1016/j.jab.2016.01.005
– volume: 25
  start-page: 1
  year: 2020
  ident: ref_39
  article-title: Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes
  publication-title: J. Adv. Res.
– volume: 12
  start-page: 4807
  year: 2006
  ident: ref_3
  article-title: Etiopathogenesis of inflammatory bowel diseases
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v12.i30.4807
– volume: 201
  start-page: 389
  year: 2019
  ident: ref_8
  article-title: Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7
  publication-title: Arch. Microbiol.
  doi: 10.1007/s00203-019-01625-z
– volume: 16
  start-page: 241
  year: 2018
  ident: ref_14
  article-title: Effect of selected 8-hydroxyquinoline-2-carboxanilides on viability and sulfate metabolism of Desulfovibrio piger
  publication-title: J. Appl. Biomed.
  doi: 10.1016/j.jab.2018.01.004
– volume: 13
  start-page: 25
  year: 1984
  ident: ref_52
  article-title: A critical review of the literature on hydrogen sulfide toxicity
  publication-title: CRC Crit. Rev. Toxicol.
  doi: 10.3109/10408448409029321
– volume: 12
  start-page: 82
  year: 2017
  ident: ref_30
  article-title: Production of biogas: Relationship between methanogenic and sulfate-reducing microorganisms
  publication-title: Open Life Sci.
  doi: 10.1515/biol-2017-0009
– ident: ref_9
  doi: 10.3390/jcm8071054
– volume: 99
  start-page: 938
  year: 2004
  ident: ref_2
  article-title: Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications
  publication-title: Am. J. Gastroenterol.
  doi: 10.1111/j.1572-0241.2004.04129.x
– volume: 86
  start-page: 405
  year: 2017
  ident: ref_27
  article-title: Kinetic properties of growth of intestinal sulphate-reducing bacteria isolated from healthy mice and mice with ulcerative colitis
  publication-title: Acta Vet. Brno
  doi: 10.2754/avb201786040405
– volume: 4
  start-page: 9
  year: 2003
  ident: ref_11
  article-title: Intestinal Bacteria and Ulcerative Colitis
  publication-title: Curr. Issues Intest. Microbiol.
– volume: 62
  start-page: 1037
  year: 2015
  ident: ref_22
  article-title: Activity and kinetic properties of phosphotransacetylase from intestinal sulfate-reducing bacteria
  publication-title: Acta Biochem. Pol.
– volume: 39
  start-page: 1
  year: 1996
  ident: ref_19
  article-title: Hydrogen sulphide: A bacterial toxin in ulcerative colitis?
  publication-title: Gut
  doi: 10.1136/gut.39.1.1
– volume: 36
  start-page: 106
  year: 2015
  ident: ref_15
  article-title: Activity of selected salicylamides against intestinal sulfate-reducing bacteria
  publication-title: Neuro Endocrinol. Lett.
– volume: 27
  start-page: 278
  year: 2018
  ident: ref_38
  article-title: Activity of ring-substituted 8-hydroxyquinoline-2-carboxanilides against intestinal sulfate-reducing bacteria Desulfovibrio piger
  publication-title: Med. Chem. Res.
  doi: 10.1007/s00044-017-2067-7
– volume: 86
  start-page: 103
  year: 1991
  ident: ref_12
  article-title: Growth and activities of sulphate-reducing bacteria in gut contents of health subjects and patients with ulcerative colitis
  publication-title: FEMS Microbiol. Ecol.
  doi: 10.1111/j.1574-6968.1991.tb04799.x
– volume: 40
  start-page: 107
  year: 2002
  ident: ref_6
  article-title: Sulphate-reducing bacteria in human feces and their association with inflammatory diseases
  publication-title: FEMS Microbiol. Ecol.
  doi: 10.1111/j.1574-6941.2002.tb00942.x
– volume: 26
  start-page: 238
  year: 1976
  ident: ref_41
  article-title: Emendation of Bacteroidaceae and Butyrivibrio and descriptions of Desulfomonas gen. nov. and ten new species of the genera Desulfomonas, Butyrivibrio, Eubacterium, Clostridium and Ruminococcus
  publication-title: Int. J. Syst. Bact.
  doi: 10.1099/00207713-26-2-238
– ident: ref_10
  doi: 10.3390/biom9120752
– volume: 96
  start-page: 151
  year: 2009
  ident: ref_7
  article-title: Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis
  publication-title: Br. J. Surg.
  doi: 10.1002/bjs.6454
– volume: 13
  start-page: 481
  year: 2018
  ident: ref_33
  article-title: Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis
  publication-title: Open Life Sci.
  doi: 10.1515/biol-2018-0057
– volume: 13
  start-page: 344
  year: 2018
  ident: ref_26
  article-title: Metabolic activity of sulfate-reducing bacteria from rodents with colitis
  publication-title: Open Med.
  doi: 10.1515/med-2018-0052
– volume: 4
  start-page: 9
  year: 2006
  ident: ref_54
  article-title: Evidence that hydrogen sulfide is a genotoxic agent
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-05-0126
– ident: ref_25
  doi: 10.3390/molecules21111558
– volume: 65
  start-page: 103
  year: 1988
  ident: ref_28
  article-title: Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut
  publication-title: J. Appl. Bacteriol.
  doi: 10.1111/j.1365-2672.1988.tb01498.x
– ident: ref_43
– volume: 13
  start-page: 119
  year: 2018
  ident: ref_31
  article-title: A new combination of substrates: Biogas production and diversity of the methanogenic microorganisms
  publication-title: Open Life Sci.
  doi: 10.1515/biol-2018-0017
– volume: 6
  start-page: 140
  year: 1993
  ident: ref_49
  article-title: Sulfate in food and beverages
  publication-title: J. Food Compos. Anal.
  doi: 10.1006/jfca.1993.1016
SSID ssj0000884217
Score 2.2846553
Snippet Background: Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing...
Inflammatory bowel diseases (IBDs) are multifactorial illnesses of the intestine, to which microorganisms are contributing. Among the contributing...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1920
SubjectTerms Bacteria
Bowel disease
Clinical medicine
Feces
Inflammatory bowel disease
Metabolism
Microbiota
Microorganisms
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwELUqkBAXxE7ZZAQXDoE0znpAiK1qkYoQUIlb5Dq2AJWUpZXgG_hp3mSDAuIaT5woY8-8F9tvGNtxA6RtWnCPXKUtZLzQAg9xLOWphkTCdBJDh5M7F36r657ferc1VtbvLD7g65_UjupJdV_6e2_P74eY8AfEOEHZ9x_UY2QTEQB1n0RG8omEdQqYn0XkMHQBvXN10h-3jOejXyDz517Jb8mnOctmCtTIj3I3z7GaTufZVKdYF19gH2eVaDcfGJ5t6yyjGr-UtAGLVDSpjX4BYlpTd9ejvgHUtK5IvhUpjB_n0s2StzEi0ZJwOn2CDjLt1VfcQNVUyDK73j4-5TJNeH6U6Z1fZrvRF1m3eXZz0rKKMguWQjYfWpiRnoDDeg3HF0ZoA5KiVRIFPSfxjLYlQIYMVSSEYye-lLaPmKga2sheaKQ0YolNpINUrzButLGV1F7DTxLXs6WMhK9cI0MEEuA0XWe75ceOVaFBTqUw-jG4CDkm_nJMnW1Xtk-58safVuulz-Jy8MQAeWC6CC5RnW1VzZg3tBgiUz0YwcYlGZowjNDFcu7i6jECccxDBqmzYMz5lQFpco-3pPd3mTZ3ILwAMHL1_9daY9MO8XaqgRSts4nhy0hvANwMe5vZyP0EXAj9SA
  priority: 102
  providerName: Scholars Portal
Title Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People
URI https://www.ncbi.nlm.nih.gov/pubmed/32575467
https://www.proquest.com/docview/2641063199
https://www.proquest.com/docview/2416938890
https://pubmed.ncbi.nlm.nih.gov/PMC7357025
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9tAEB61IKFeEAXaplC0CC4cLByvnydEIAgqBUU8pNyszT5Eq9SBJjnwG_jTfGM7htCKo73jteV5785-Q7QfJnDbvOGehdp68Hiphzwk8HSk2woOMzCODyf3LuPz2_DnIBrUC26TuqxybhNLQ23GmtfID-G4kb1AYLKj-wePu0bx7mrdQuMjLZfQZZDnZJA0ayzQoBAhd4VKKpHdH_7WfzKfcwZ_0Q_9E1y-rZF85XTO1mi1jhbFccXez_TBFuu00qv3wzfoqduAdYuxE2U559yaib7iwitGz-QxXvqDOvN017ORQ4jpXTFsK1yX6FSQzUpcQBIxYgSfOsEEJebqBA9wFxWmLO9fdE6FKoyojjA9in5Zhb5Jt2fdm5Nzr26v4Gl48akHTYwkGDVsB7F00jokJ1abLBkGJnLWVwguVKozKQPfxEr5MWyhblunhqlTyskvtFSMC_uNhLPO18pG7diYMPKVymSsQ6dSGBDEZ7ZFB_Ofnesae5xbYIxy5CDMmPyFMS3aa2jvK8SN_1Jtz3mW11o3yV9kpEW7zTD0hTdBVGHHM9CEDD-Tphmm-FqxuHmNhP2K4DlalCwwvyFgLO7FkeLXXYnJncgoQfj4_f3P2qJPAefr3Pso26al6d-Z_YGgZjrcKSV3h5Y73cv-Fa56YfoMHCb9tg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbhNBEC0FRwIuiB1DgEbAgcMo4-lZDwhh4sgmsWWFRMpt0u5FgMI4YFso38C_8I28mi0YELdc3T3t0VR1varuqldEL8IEsM0X7lmorQfESz3EIYGnI91TAMzAOC5OHk_i4VH4_jg63qCfTS0Mp1U2NrE01Gau-Yx8G8CN6AUKk705--px1yi-XW1aaFRqsWfPvyNkW7we7UC-L4Ngd3D4bujVXQU8DfBaelDASOL9Zr0glk5aB5_capMls8BEzvoKmKpSjUA_8E2slB_DBOiedWqWOqWcxLpXaDPkitYObfYHk-lBe6qDPRvCya94UKXM_O3P-kvmc5TiryPfX-7sn1mZv8Hc7k26Ufun4m2lULdowxa36eq4voG_Qz8GLT24mDtRJpA29lNMFad6MV8nj_FhIwwIL_dhderg1HoHTBQLsBT9iiRaiRF0HyNGcJ0LFihZXhd4gPu28Mzy91F_R6jCiKpo6lxMy7z3u3R0KZ_-HnWKeWEfkHDW-VrZqBcbE0a-UpmMdehUCpMFj9B26VXzsXNds51z043THFEPCya_EEyXnrdzzyqOj3_O2mpkltf7fJFfaGWXnrXD2KF87aIKO19hTsiEN2maYYn7lYjbv5GwmBGwqkvJmvDbCcz-vT5SfPpYsoAnMkrgsD78_2s9pWvDw_F-vj-a7D2i6wGfFnDnpWyLOstvK_sYLtVy9qTWY0Enl711fgHURzso
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbhNBEC2FRIq4oLCbhNAIOHAYeTw96wEhEseKCYksIJJvk3YvAhTGIbYV5Rv4I76OV7MlBsQtV3dPezS1vKru6ldEL8MEsM0H7lmorQfESz3kIYGnI91TAMzAOL6cfHgU7x-H78fReIV-NXdhuKyy8YmlozZTzXvkXQA3shcoTNZ1dVnEqD94e_bD4w5SfNLatNOoVOTAXl4gfZu9GfYh61dBMNj7vLvv1R0GPA0gm3tQxkjiXSe9IJZOWof43GqTJZPARM76CviqUo2kP_BNrJQfwx3onnVqkjqlnMS6t2gtkYiqYEvJOGn3d2C9IcL9ihFVyszvftPfM5_zFX8ZA_8KbP-sz7wGeIMNulNHquJdpVp3acUW92j9sD6Lv08_91qicDF1oiwlbTypGCku-mLmTh7jbUe4El7u0-LUIbz1PjJlLGBT7FR00UoMYQUYMYJvvGCBku91hge4gwvPLH8f7vSFKoyork9dilFZAf-Ajm_kwz-k1WJa2McknHW-VjbqxcaEka9UJmMdOpXCeSE2tB163XzsXNe859x-4zRH_sOCya8E06EX7dyziu3jn7O2GpnltcXP8iv97NDzdhi2ygcwqrDTBeaETH2TphmWeFSJuP0bCd8ZAbU6lCwJv53APODLI8XXLyUfONQvQej65P-v9YzWYTD5h-HRwSbdDnjbgFswZVu0Oj9f2KeIreaT7VKJBZ3ctNX8Bo_RPe8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+Physiological+Parameters+of+Intestinal+Sulfate-Reducing+Bacteria+Isolated+from+Patients+Suffering+from+IBD+and+Healthy+People&rft.jtitle=Journal+of+clinical+medicine&rft.au=Kushkevych%2C+Ivan&rft.au=Jorge+Castro+Sangrador&rft.au=Dordevi%C4%87%2C+Dani&rft.au=Rozehnalov%C3%A1%2C+Monika&rft.date=2020-06-19&rft.pub=MDPI+AG&rft.eissn=2077-0383&rft.volume=9&rft.issue=6&rft.spage=1920&rft_id=info:doi/10.3390%2Fjcm9061920&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon